Bio-Connect
IHC-P analysis of human tonsil tissue section using GTX02590 Annexin A1 antibody [ANXA1/3869R].
IHC-P analysis of human tonsil tissue section using GTX02590 Annexin A1 antibody [ANXA1/3869R].
IHC-P analysis of human tonsil tissue section using GTX02590 Annexin A1 antibody [ANXA1/3869R].

Annexin A1 antibody [ANXA1/3869R]

GTX02590
GeneTex
ApplicationsImmunoPrecipitation, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse
TargetANXA1
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    Annexin A1 antibody [ANXA1/3869R]
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1-2 microg/ml. IHC-P: 1-2 microg/ml. IP: 2-4 microg/mg protein. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoPrecipitation, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    ANXA1/3869R
  • Concentration
    200 ug/ml
  • Conjugate
    Unconjugated
  • Gene ID301
  • Target name
    ANXA1
  • Target description
    annexin A1
  • Target synonyms
    annexin A1; annexin I (lipocortin I); annexin-1; ANX1; calpactin II; calpactin-2; chromobindin-9; epididymis secretory sperm binding protein; LPC1; phospholipase A2 inhibitory protein
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP04083
  • Protein Name
    Annexin A1
  • Scientific Description
    This gene encodes a membrane-localized protein that binds phospholipids. This protein inhibits phospholipase A2 and has anti-inflammatory activity. Loss of function or expression of this gene has been detected in multiple tumors. [provided by RefSeq, Dec 2014]
  • Reactivity
    Human, Mouse
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Antibody-activated trans-endothelial delivery of mesoporous organosilica nanomedicine augments tumor extravasation and anti-cancer immunotherapy. Huang T et al., 2021 Jul, Bioact Mater
    Read more